Search
Search
Development decisions made without manufacturing context carry a cost. Process choices around media formulation, feeding strategies, and bioreactor conditions that appear viable at bench scale may be difficult to execute or transfer once manufacturing constraints are introduced.
The Baltimore, Maryland location is a development-focused site designed to support process scientists and engineers earlier in program timelines, before those constraints become obstacles. With dedicated laboratories, pilot-scale capabilities, and Gibco Media by Design Services, the Baltimore facility is structured to support early workflow evaluation and process planning within the broader bioprocessing network.
| Highlight | Detail |
| Services | Gibco Media by Design Services process development, Cell culture labs, Pilot labs, Gibco Rapid Prototyping Services, Analytical chemistry lab |
| Key manufacturing capability | Non-cGMP cell culture media |
The Baltimore site's laboratories and services are used to inform process choices, assess development readiness, and reduce uncertainty before scale-up or technology transfer. From media customization and bioreactor characterization to pilot-scale prototyping and analytical data generation, each capability is designed to help process teams build a stronger foundation for downstream manufacturing decisions.
Customized media formulation and process development are central to the Gibco Media by Design Services offered at this location. Development specialists work alongside process scientists to evaluate formulations tailored to specific cell lines, culture formats, and process requirements, with the goal of identifying configurations compatible with manufacturing environments before making scale-up commitments. By incorporating considerations early in formulation work, these services are designed to reduce the need for late-stage reformulation.
A dedicated cell culture laboratory enables development-stage experimentation across upstream workflows. Scientists evaluating cell culture conditions, including media composition, supplementation strategies, and growth environment parameters, can assess candidate approaches under controlled conditions representative of early-stage process development. Data generated during these evaluations can inform subsequent decisions regarding bioreactor operation and pilot-scale progression.
Characterizing process behavior and performance at the development scale is the bioreactor laboratory's primary function. Scientists and process engineers can evaluate parameters such as dissolved oxygen, pH control, agitation, and feeding regimens under conditions that represent the upstream manufacturing environment. Support more informed decision-making before processes advance to pilot or manufacturing settings and reduce the risk of encountering scale-dependent variability late in development timelines.
The pilot-scale laboratory enables evaluation of media formulations, raw material changes, and process adjustments at scale prior to full manufacturing execution. Gibco Rapid Prototyping Services are available in this environment, enabling teams to assess formulation concepts, evaluate the impact of ingredient substitutions, and prototype process modifications before committing to manufacturing-scale runs. For process development teams working to verify decisions before transferring to commercial production, these pilot-scale capabilities are designed to reduce uncertainty.
Process understanding, development planning, and troubleshooting across upstream workflows depend on reliable analytical data. The analytical chemistry laboratory allows characterization of media components, evaluation of raw material quality, and generation of datasets that inform process decisions at development and pilot scale. When unexpected results arise during cell culture or bioreactor work, analytical data can support root cause investigation and guide adjustments before they affect downstream operations or manufacturing timelines.
For Research Use or Further Manufacturing. Not for diagnostic use or direct administration into humans or animals.